Mariner
PCVX icon

Mariner’s Vaxcyte PCVX Stock Holding History

Mariner’s Portfolio PCVX Stock Details PCVX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$555K Sell
9,545
-3,435
-26% -$187K ﹤0.01% 2382
2026
Q1 		$754K Buy
12,980
+4,441
+52% +$241K ﹤0.01% 2171
2025
Q4 		$394K Buy
8,539
+784
+10% +$35.1K ﹤0.01% 2628
2025
Q3 		$279K Buy
+7,755
New +$257K ﹤0.01% 2873
2025
Q2 		– Sell
-7,945
Closed -$300K – 3632
2025
Q1 		$300K Buy
7,945
+1,998
+34% +$160K ﹤0.01% 2623
2024
Q4 		$487K Buy
5,947
+1,290
+28% +$128K ﹤0.01% 2216
2024
Q3 		$531K Buy
4,657
+465
+11% +$41.9K ﹤0.01% 2082
2024
Q2 		$317K Buy
4,192
+502
+14% +$34.2K ﹤0.01% 2409
2024
Q1 		$252K Buy
+3,690
New +$256K ﹤0.01% 2589

Other funds holding PCVX

Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
JT
Jupiter Topco New York $245B AUM
T. Rowe Price Investment Management
T. Rowe Price Investment Management Baltimore, Maryland $153B AUM 38.14% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
RCM
RA Capital Management Boston, Massachusetts $11.5B AUM 168.77% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
DTC
Deep Track Capital Greenwich, Connecticut $6.87B AUM 205.24% 1-Year Est. Return

Mariner's PCVX Position: Q2 2026 in Review

Mariner reduced its Vaxcyte (PCVX) stake by 26% in Q2 2026, selling an estimated $187K and leaving 9,545 shares worth $555K. The position accounts for ﹤0.01% of the portfolio, ranked #2382.

Mariner first reported a position in PCVX in Q1 2024 and has held it in 9 quarters since. The position peaked at $754K in Q1 2026. 332 funds tracked by Wall St. Rank hold PCVX as of Q2 2026.

  • Mariner held 9,545 shares of Vaxcyte worth $555K as of Q2 2026.
  • Mariner sold 3,435 Vaxcyte shares in Q2 2026, an estimated $187K.
  • Vaxcyte made up ﹤0.01% of Mariner's portfolio in Q2 2026, its #2382 holding.
  • Mariner first reported a position in Vaxcyte in Q1 2024 and has held it in 9 quarters since.
  • Mariner's Vaxcyte position peaked at $754K in Q1 2026.
  • 332 funds tracked by Wall St. Rank held Vaxcyte as of Q2 2026.

Based on Mariner's 13F filing for Q2 2026, filed 13 Aug 2026.